Stock Research for ARCVF

ARCVF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ARCVF Stock Chart & Research Data

The ARCVF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARCVF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ARCVF Due diligence Resources & Stock Charts

The ARCVF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ARCVF Detailed Price Forecast - CNN Money CNN View ARCVF Detailed Summary - Google Finance
Yahoo View ARCVF Detailed Summary - Yahoo! Finance Zacks View ARCVF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ARCVF Trends & Analysis - Trade-Ideas Barrons View ARCVF Major Holders - Barrons
NASDAQ View ARCVF Call Transcripts - NASDAQ Seeking View ARCVF Breaking News & Analysis - Seeking Alpha
Spotlight View ARCVF Annual Report - CompanySpotlight.com OTC Report View ARCVF OTC Short Report - OTCShortReport.com
TradeKing View ARCVF Fundamentals - TradeKing Charts View ARCVF SEC Filings - Bar Chart
WSJ View Historical Prices for ARCVF - The WSJ Morningstar View Performance/Total Return for ARCVF - Morningstar
MarketWatch View the Analyst Estimates for ARCVF - MarketWatch CNBC View the Earnings History for ARCVF - CNBC
StockMarketWatch View the ARCVF Earnings - StockMarketWatch MacroAxis View ARCVF Buy or Sell Recommendations - MacroAxis
Bullish View the ARCVF Bullish Patterns - American Bulls Short Pains View ARCVF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ARCVF Stock Mentions - StockTwits PennyStocks View ARCVF Stock Mentions - PennyStockTweets
Twitter View ARCVF Stock Mentions - Twitter Invest Hub View ARCVF Investment Forum News - Investor Hub
Yahoo View ARCVF Stock Mentions - Yahoo! Message Board Seeking Alpha View ARCVF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ARCVF - SECform4.com Insider Cow View Insider Transactions for ARCVF - Insider Cow
CNBC View ARCVF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ARCVF - OTC Markets
Yahoo View Insider Transactions for ARCVF - Yahoo! Finance NASDAQ View Institutional Holdings for ARCVF - NASDAQ


Stock Charts

FinViz View ARCVF Stock Insight & Charts - FinViz.com StockCharts View ARCVF Investment Charts - StockCharts.com
BarChart View ARCVF Stock Overview & Charts - BarChart Trading View View ARCVF User Generated Charts - Trading View




Latest Financial News for ARCVF


Is Arcadis NV's (AMS:ARCAD) Recent Stock Performance Tethered To Its Strong Fundamentals?
Posted on Sunday March 24, 2024

Arcadis (AMS:ARCAD) has had a great run on the share market with its stock up by a significant 20% over the last three...


Here's Why We Think Arcadis (AMS:ARCAD) Is Well Worth Watching
Posted on Sunday March 10, 2024

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...


Arcadis Full Year 2023 Earnings: Revenues In Line With Expectations
Posted on Friday February 23, 2024

Arcadis ( AMS:ARCAD ) Full Year 2023 Results Key Financial Results Revenue: €5.00b (up 24% from FY 2022). Net income...


Arcadis Q4 and Full Year 2023 Results: Record quarter performance and delivery on 2021-2023 targets
Posted on Wednesday February 21, 2024

PRESS RELEASE Arcadis Fourth Quarter and Full Year Results 2023Record quarter performance and delivery on 2021-2023 targets FOURTH QUARTER Record Operating EBITA margin1) of 11.4% (Q4‘22: 10.0%)Record Q4 Order Intake of €1,028 million resulting in Book to Bill of 1.09xRecord Free Cash Flow generation of €208 million (Q4‘22: €146 million) FULL YEAR Delivered on all key strategic targets set for 2021-2023 strategy cycle “Maximizing Impact”Operating EBITA margin of 10.4% (FY ‘22: 9.8%)Record net re


Stock Market & Investing Books

Enter a stock symbol to view the stock details.